The importance of these pathways in glioma has been well-described in the literature; ultimately, these tumors harbor mutations that continuously activate these protein kinase signaling pathways, leading to increased tumorigenesis and progression [346,347,348]. Here, WEE1 is linked to central nervous system cancer.